Kura Oncology Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
1.50
20.00
31.00
30.00
10
Gross Income
1.50
20.00
31.00
30.00
10
SG&A Expense
3,932.70
23,577.00
28,336.00
36,047.00
62,873
EBIT
3,934.20
23,597.00
28,367.00
36,077.00
62,883
Unusual Expense
-
268.00
-
-
498
Non Operating Income/Expense
300.00
1,200.00
885.00
780.00
735
Interest Expense
37.10
88.00
577.00
888.00
970
Pretax Income
3,671.30
22,625.00
27,560.00
35,434.00
60,447
Consolidated Net Income
3,671.30
22,625.00
27,560.00
35,434.00
60,447
Net Income
3,671.30
22,625.00
27,560.00
35,434.00
60,447
Net Income After Extraordinaries
3,671.30
22,625.00
27,560.00
35,434.00
60,447
Net Income Available to Common
3,671.30
22,625.00
27,560.00
35,434.00
60,447
EPS (Basic)
12.99
2.28
1.47
1.52
1.72
Basic Shares Outstanding
18,820.70
9,933.00
18,701.00
23,237.00
35,191
EPS (Diluted)
0.20
2.28
1.47
1.52
1.72
Diluted Shares Outstanding
18,820.70
9,933.00
18,701.00
23,237.00
35,191
EBITDA
3,932.70
23,577.00
28,336.00
36,047.00
62,873
Non-Operating Interest Income
-
128.00
499.00
751.00
3,169
About Kura Oncology
View Profile
